Recommendation of the President – Coatoris (ezetimibe + atorvastatin, 10 mg + 80 mg)
On 21 January 2026, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 7/2026 on the reimbursement of the medicinal product Coatoris (ezetimibe + atorvastatin, 10 mg + 80 mg) for the following indications: prevention of cardiovascular events, hypercholesterolemia, homozygous familial hypercholesterolemia